Insider · CIK 0001860611
Jessica R. Uhl
Files at GE (GENERAL ELECTRIC CO), GS (GOLDMAN SACHS GROUP INC), FRVO (Fervo Energy Co), GEV (GE Vernova Inc.). First filing -, latest -.
In brief
Jessica R. Uhl files SEC Form 4 as president and director at GE (GENERAL ELECTRIC CO), and also at GS (GOLDMAN SACHS GROUP INC), FRVO (Fervo Energy Co), GEV (GE Vernova Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jessica R. Uhl has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 23, 2025 | GEV GE Vernova | 2,310 0.00% of outstanding | $1.1M | Jun 23, 2025 | none |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | FRVO Fervo Energy Co | AGrant or award Restricted Stock Unitsderivative | +9,259 | $0.00 | $0 | 9,259 | May 18, 2026 |
| Apr 2, 2025 | GEV GE Vernova Inc. | JOther Deferred Fee Phantom Stock Unitsderivative | -284 | $312.40 | $89k | 0 | Apr 4, 2025 |
| Mar 1, 2025 | GEV GE Vernova Inc. | MOption exercise Common stock, par value $0.01 per share | +2,667 | $0.00 | $0 | 2,667 | Mar 4, 2025 |
| Mar 1, 2025 | GEV GE Vernova Inc. | FTax withholding Common stock, par value $0.01 per share | -652 | $335.18 | $219k | 2,015 | Mar 4, 2025 |
| Mar 1, 2025 | GEV GE Vernova Inc. | MOption exercise Restricted Stock Unitsderivative | -2,667 | $0.00 | $0 | 5,415 | Mar 4, 2025 |
| Feb 28, 2025 | GEV GE Vernova Inc. | AGrant or award Restricted Stock Unitsderivative | +3,139 | $0.00 | $0 | 3,139 | Mar 4, 2025 |
| Feb 28, 2025 | GEV GE Vernova Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +6,104 | $0.00 | $0 | 6,104 | Mar 4, 2025 |
| Jun 3, 2024 | GEV GE Vernova Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +14,161 | $0.00 | $0 | 14,161 | Jun 5, 2024 |
| May 16, 2024 | GEV GE Vernova Inc. | AGrant or award Restricted Stock Unitsderivative | +8,082 | $0.00 | $0 | 8,082 | May 20, 2024 |
| May 16, 2024 | GEV GE Vernova Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +11,695 | $0.00 | $0 | 11,695 | May 20, 2024 |
| Apr 2, 2024 | GEV GE Vernova Inc. | AGrant or award Deferred Fee Phantom Stock Unitsderivative | +284 | - | - | 284 | Apr 4, 2024 |
| Mar 28, 2024 | GE GENERAL ELECTRIC CO | AGrant or award Deferred Fee Phantom Stock Unitsderivative | +63 | $169.15 | $11k | 1,136 | Apr 1, 2024 |
| Jan 17, 2024 | GS GOLDMAN SACHS GROUP INC | AGrant or award Restricted Stock Unitsderivative | +927 | $0.00 | $0 | 2,738 | Jan 19, 2024 |
| Dec 29, 2023 | GE GENERAL ELECTRIC CO | AGrant or award Deferred Fee Phantom Stock Unitsderivative | +376 | $123.54 | $46k | 1,073 | Jan 3, 2024 |
Questions about Jessica R. Uhl
Answered from the filings on this page, as of the latest one.
Is Jessica R. Uhl buying or selling?
Jessica R. Uhl has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jessica R. Uhl's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jessica R. Uhl has 0.
Where does Jessica R. Uhl file Form 4?
Jessica R. Uhl has filed Form 4 at GE (GENERAL ELECTRIC CO); GS (GOLDMAN SACHS GROUP INC); FRVO (Fervo Energy Co); GEV (GE Vernova Inc.) as President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.